Prosecutors seeking 15 years behind bars for Theranos CEO Elizabeth Holmes


Federal prosecutors are recommending a sentence of 15 years in prison for disgraced Theranos founder Elizabeth Holmes, Reuters reported Friday.
Holmes, 38, was found guilty this past January of defrauding investors about the merits of Theranos' blood-testing machines. She is facing a maximum of 20 years in prison, though experts predicted her actual sentence would likely be shorter.
In addition to the recommended sentence, U.S. attorneys said Holmes should be forced to pay $800 million in restitution to investors, per Reuters.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Holmes is scheduled to be sentenced next week, and her time in prison will be the final domino to fall in one of the largest investment fraud schemes in American history, as well as one of the most notable falls from grace in tech history. Forbes had at one point named Holmes the youngest self-made female billionaire in the country, and Theranos had an estimated valuation of $9 billion.
However, an investigation by The Wall Street Journal soon revealed that Holmes and other top officials at Theranos had lied to investors about the accuracy and capabilities of their blood-testing machines. As the investigation grew to involve the federal government, Theranos' value soon plunged to zero, and the SEC soon charged Holmes with "massive fraud" related to her running of the company.
According to reports from The Associated Press and Bloomberg, Holmes is seeking an 18-month house arrest sentence in lieu of prison time. However, it was noted that, given the scope of her crimes, this request was unlikely to be granted.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
June 25 editorial cartoons
Cartoons Wednesday's cartoons include war on a loop, the New York City mayoral race, and one almighty F-bomb
-
How generative AI is changing the way we write and speak
In The Spotlight ChatGPT and other large language model tools are quietly influencing which words we use
-
How long can Nato keep Donald Trump happy?
Today's Big Question Military alliance pulls out all the stops to woo US president on his peacemaker victory lap
-
Climate change can impact our gut health
Under the radar The gastrointestinal system is being gutted
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
Children's breakfast cereals are getting more unhealthy
Under the radar Your kids may be starting their day with more than a spoonful of sugar
-
The marvelous powers of mucus
The Explainer It's snot just a pesky cold symptom
-
'Wonder drug': the potential health benefits of creatine
The Explainer Popular fitness supplement shows promise in easing symptoms of everything from depression to menopause and could even help prevent Alzheimer's
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
A tick-borne illness is making its rounds in new parts of America
Under the radar Babesiosis, spread through blacklegged or deer tick bites, is a growing risk